Diagnosis of Infectious Mononucleosis
The VIDAS® Epstein-Barr Virus (EBV) panel provides a combination of three tests to rapidly confirm a diagnosis of Infectious Mononucleosis and clearly establish the stage of infection.
4 EBV-specific markers in 3 tests for a confident diagnosis
Flexible solution adapted to small-volume testing
Automated diagnosis you can perform in your own lab to provide same-day results to clinicians
Through detection of the main causative agent of Infectious Mononucleosis (IM), the VIDAS® EBV panel helps confirm a clinical diagnosis of the disease and rule out other pathologies which may produce IM-type symptoms. Rapid and clear diagnosis enables to reassure patients and physicians and avoid unnecessary investigations and treatment.
The panel includes three automated tests for the qualitative detection of anti-VCA IgM, anti-EBNA IgG and anti-VCA IgG/anti-EA IgG antibodies in human serum using the ELFA technique. Based on proprietary peptides, these assays are designed to provide the most relevant antibody responses to confidently define patient status.
The full serological picture
Rational criteria to define EBV patient status in immunocompetent individuals
The VIDAS® EBV-specific tests are related to the time-dependent antibody response to various antigens produced during the Epstein-Barr Virus life cycle.
3 serological parameters - VCA IgM, VCA IgG and EBNA IgG – are necessary for EBV stage-specific diagnosis2,3:
Absence of infection